Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention

Published:2021-11 Issue:5 Volume:75 Page:1217-1227
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lange Naomi F.,Radu Pompilia,Dufour Jean-François

Funder

Swiss Life Stiftung für Chancenreichtum und Zukunft

Gottfried und Julia Bangerter-Rhyner-Stiftung

Schweizerische Akademie der Medizinischen Wissenschaften

Publisher

Elsevier BV

Subject

Hepatology

Reference117 articles.

1. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases;Stine;Aliment Pharmacol Ther,2018

2. Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease;Kanwal;Hepatology,2020

3. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease;Kanwal;Gastroenterology,2018

4. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer;Lee;Int J Epidemiol,2009

5. Composite score of healthy lifestyle factors and risk of hepatocellular carcinoma: findings from a prospective cohort study;Luu;Canc Epidemiol Biomark Prev,2021

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers;Metabolism;2024-11

2. Metabolic dysfunction-associated steatotic liver disease and its link to cancer;Metabolism;2024-11

3. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors;Pharmacological Research;2024-10

4. Letter: Enhancing cirrhosis management—The critical role of social workers in supporting NAFLD surveillance;Alimentary Pharmacology & Therapeutics;2024-09-09

5. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response;Bioorganic Chemistry;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3